Tyrosine kinase expression profile in clear cell renal cell carcinoma (Q85037235)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21969129%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Tyrosine kinase expression profile in clear cell renal cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21969129%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

Turang E Behbahani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21969129%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Claudia Thierse

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21969129%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Claudia Baumann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21969129%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Daniel Holl

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21969129%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Patrick J Bastian

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21969129%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Alexander von Ruecker

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21969129%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Stefan C Müller

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21969129%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Jörg Ellinger

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21969129%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Stefan Hauser

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21969129%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

4 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21969129%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

published in

World Journal of Urology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21969129%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21969129%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

559-565

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21969129%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21969129%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00345-011-0767-z

14 February 2020

exact match

0 references

cites work

JAK kinases promote invasiveness in VHL-mediated renal cell carcinoma by a suppressor of cytokine signaling-regulated, HIF-independent mechanism

1 reference

12 December 2020

Sunitinib in metastatic renal cell carcinoma: recommendations for management of noncardiovascular toxicities.

1 reference

12 December 2020

Prognostic factors in renal cell carcinoma

1 reference

12 December 2020

Prognostic significance of CD44, platelet-derived growth factor receptor alpha, and cyclooxygenase 2 expression in renal cell carcinoma

1 reference

12 December 2020

Granulocyte colony-stimulating factor/granulocyte colony-stimulating factor receptor biological axis promotes survival and growth of bladder cancer cells

1 reference

12 December 2020

Soluble Tie2 and Flt1 extracellular domains in serum of patients with renal cancer and response to antiangiogenic therapy.

1 reference

12 December 2020

Prognostic evaluation of COX-2 expression in renal cell carcinoma

1 reference

12 December 2020

Pazopanib, a VEGF receptor tyrosine kinase inhibitor for cancer therapy

1 reference

12 December 2020

Risk stratification and prognostication of renal cell carcinoma

1 reference

12 December 2020

SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types

1 reference

12 December 2020

Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma

1 reference

12 December 2020

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

1 reference

12 December 2020

Investigation of the prognostic value of coexpressed erbB family members for the survival of colorectal cancer patients after curative surgery

1 reference

12 December 2020

Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique

1 reference

12 December 2020

Activation of tyrosine kinases in cancer

1 reference

12 December 2020

Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.

1 reference

12 December 2020

Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma

1 reference

12 December 2020

Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention

1 reference

12 December 2020

Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma

1 reference

12 December 2020

Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation.

1 reference

12 December 2020

A phase II trial of gefitinib (Iressa, ZD1839) in stage IV and recurrent renal cell carcinoma

1 reference

12 December 2020

Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 associate with clear cell renal cell carcinoma

1 reference

12 December 2020

PDGF receptors as cancer drug targets

1 reference

12 December 2020

The protein tyrosine kinase family of the human genome

1 reference

12 December 2020

Concomitant activation of the JAK/STAT3 and ERK1/2 signaling is involved in leptin-mediated proliferation of renal cell carcinoma Caki-2 cells

1 reference

12 December 2020

ErbB4 promotes cyclooxygenase-2 expression and cell survival in colon epithelial cells

1 reference

12 December 2020

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

1 reference

12 December 2020

ErbB4 is downregulated in renal cell carcinoma--a quantitative RT-PCR and immunohistochemical analysis of the epidermal growth factor receptor family.

1 reference

12 December 2020

Update on systemic therapies of metastatic renal cell carcinoma

1 reference

12 December 2020